Inventor
MENG ZHAOYANG
US17 patents
⚠️ This page may combine multiple inventors who share the name “MENG ZHAOYANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK SHARP & DOHME
7 patentsUS10933056B2Mar 2, 2021
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor
MERCK SHARP & DOHME2 citations71
US9663506B2May 30, 2017
Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use
MERCK SHARP & DOHME2 citations70
US9636337B2May 2, 2017
Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use
MERCK SHARP & DOHME2 citations70
US11655216B2May 23, 2023
Aryl and heteroaryl ether derivatives as liver X receptor beta agonists, compositions, and their use
MERCK SHARP & DOHME0 citations49
US10961215B2Mar 30, 2021
N-aryl and N-heteroaryl piperidine derivatives as liver X receptor beta agonists, compositions, and their use
MERCK SHARP & DOHME0 citations49
US10894775B2Jan 19, 2021
Piperidine derivatives as liver X receptor beta agonists, compositions, and their use
MERCK SHARP & DOHME0 citations48
US10752587B2Aug 25, 2020
Homobispiperidinyl derivatives as liver X receptor beta agonists, compositions and their use
MERCK SHARP & DOHME0 citations38
MENG ZHAOYANG
3 patentsUS8927562B2Jan 6, 2015
Fused tricyclic inhibitors of mammalian target of rapamycin
MENG ZHAOYANG1 citations46
US8901142B2Dec 2, 2014
Fused tricyclic compounds as mTOR inhibitors
MENG ZHAOYANG0 citations36
US8703784B2Apr 22, 2014
Substituted pyrazolo[1,5-a]pyrido[3.2-e]pyrimidin-6-one inhibitors of mammalian target of rapamycin
MENG ZHAOYANG0 citations35